2
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER_GOV
1
Study Type
Observational
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
65
Neoplasm Metastasis
6
Prostatic Neoplasms, Castration-Resistant
5
Non-metastatic Castration-resistant Prostate Cancer
4
Metastatic Castration-resistant Prostate Cancer
4
Prostatic Diseases
3
Neoplasms
3
Breast Neoplasms
3
Urogenital Neoplasms
2
Triple Negative Breast Neoplasms
2
Salivary Gland Neoplasms
2
Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
2
Metastatic Hormone-sensitive Prostate Cancer
2
Male Urogenital Diseases
2
Genital Diseases, Male
2
Bulbo-Spinal Atrophy, X-Linked
2
Biochemically Recurrent Prostate Cancer
2
Adenocarcinoma
2
Urogenital Diseases
1
Thrombocytosis
1
Sleep Initiation and Maintenance Disorders
1
Prostate Cancer Non-Metastatic
1
Prostate Cancer Metastatic
1
Prostate Adenocarcinoma
1
Primary Myelofibrosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pancreatic Neoplasms
1
Non-metastatic Prostate Cancer
1
Neoplasms by Site
1
Myeloproliferative Disorders
1
Interventions
Therapeutics
31
Psychiatric Rehabilitation
27
Surveys and Questionnaires
15
Cognitive Behavioral Therapy
12
Early Intervention, Educational
10
Psilocybin
9
Ketamine
9
Methods
8
Saline Solution
7
Yoga
6
Mindfulness-Based Cognitive Therapy
6
Interviews as Topic
6
Esketamine
6
Counseling
6
Psychosocial Intervention
5
Mindfulness
5
Methylphenidate
5
Escitalopram
5
Educational Status
5
Behavior Therapy
5
Acupuncture Therapy
5
Palliative Care
4
Exercise Therapy
4
Exercise
4
Control Groups
4
Caregivers
4
Standard of Care
3
Psychotherapy
3
Niacin
3
Mindfulness-Based Stress Reduction
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Depression
×
darolutamide
×
Clear all
NCT07181122
2026-04-28
PRO-MIND
Ankara Etlik City Hospital
Recruiting
102 enrolled